Jasper Therapeutics, Inc. - 8-K Filing
Jasper Therapeutics stockholders approved a reverse stock split proposal, an increase in authorized shares, and the adjournment of their special meeting on September 30, 2026. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $JSPR